Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN IBS-C
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Elaina Rohlfing finds calling in computer science at UMSL, begins pursuit of PhD
Rohlfing is continuing to work in Assistant Professor Azim Ahmadzadeh’s lab conducting research on solar flares after finishing the accelerated master’s program in December.
MORE IN IBS-C
LATEST NEWS
- Elaina Rohlfing finds calling in computer science at UMSL, begins pursuit of PhD
- UMSL students chosen to perform with Missouri All-Collegiate Orchestra at Missouri Music Educators Association Conference
- Study Abroad Fair exposes UMSL students to world of possibilities as they look to expand their academic experience
- Eye on UMSL: Hitting the books
- Eye on UMSL: Snow day
- UMSL Tritons weekly rewind
- Chancellor Kristin Sobolik joins Pulse of St. Louis to discuss how UMSL is changing to meet the needs of students and St. Louis region
- UMSL alum and retiring St. Louis Mercantile Library curator Julie Dunn-Morton helps create new art gallery as legacy project
- US News ranks UMSL 11th nationally for Best Online Bachelor’s Programs
- Lauren Pflug, Matthew Henry and Vivek Singh receive UMSL Hero Awards
